DelveInsight has launched a new report on “Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Microsatellite Stable Colorectal Cancer, historical and forecasted epidemiology as well as the Microsatellite Stable Colorectal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key benefits of the report:
- Microsatellite Stable Colorectal Cancer market report covers a descriptive overview and comprehensive insight of the Microsatellite Stable Colorectal Cancer Epidemiology and Microsatellite Stable Colorectal Cancer market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Microsatellite Stable Colorectal Cancer market report provides insights on the current and emerging therapies.
- Microsatellite Stable Colorectal Cancer market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Microsatellite Stable Colorectal Cancer market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Microsatellite Stable Colorectal Cancer market.
Got queries? Click here to know more about the Microsatellite Stable Colorectal Cancer Market Landscape
Some of the key facts of the Microsatellite Stable Colorectal Cancer Market Report:
- The incidence of CRC for ages 20-49 years of age has increased by 47% in the past decades, and for age groups 50 years or older, there is a slight decrease.
- Globally the Microsatellite Stable Colorectal Cancer is responsible for 4 out of 10 people affected with the colorectal cancer
- In the United States, Colorectal Cancer is the third most common cancer in men and woman
- In the year 2021, the incidence of colorectal cancer was estimated at 1.9 million worldwide
Request a sample for the Report: https://www.delveinsight.com/sample-request/microsatellite-stable-colorectal-cancer-market
Microsatellite Stable Colorectal Cancer Overview:
About 15% of the Colorectal Cancers are caused due to Microsatellite instability. Microsatellite Instability is the molecular fingerprint of a deficient mismatch repair system. When the number of Microsatellites repeats is the same in all the cells then the DNA is considered stable.
If the cancer is diagnosed at the starting stage, the chances of survival become 91%. If cancer has spread to the surrounding tissues or organs the survival rate becomes less counting to 72%, and the survival rate is lowest if cancer has spread to other distant parts of the body, counting to 14%.
Microsatellite Stable Colorectal Cancer Symptoms:
The symptoms of Microsatellite Stable Colorectal Cancer include-
- Abrupt weight loss
- Body Fatigue
- Change in bowel habits
- Blood in stool
- Rectal bleeding
Microsatellite Stable Colorectal Cancer Market
The dynamics of the Microsatellite Stable Colorectal Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Grapiprant, Nivolumab, Ipilimumab, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Microsatellite Stable Colorectal Cancer Market Landscape
Microsatellite Stable Colorectal Cancer Pipeline Therapies:
- Grapiprant
- Nivolumab
- Ipilimumab
- CR6086
- Navarixin
- BMS-986340
Microsatellite Stable Colorectal Cancer Pipeline Key Companies:
- Rottapharm Biotech
- Arrys Therapeutics
- Effector Therapeutics
- Novartis Pharmaceuticals
- Gossamer Bio
- Bayer
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Microsatellite Stable Colorectal Cancer Patient Share (%) Overview at a Glance
5. Microsatellite Stable Colorectal Cancer Market Overview at a Glance
6. Microsatellite Stable Colorectal Cancer Disease Background and Overview
7. Microsatellite Stable Colorectal Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Microsatellite Stable Colorectal Cancer
9. Microsatellite Stable Colorectal Cancer Current Treatment and Medical Practices
10. Unmet Needs
11. Microsatellite Stable Colorectal Cancer Emerging Therapies
12. Microsatellite Stable Colorectal Cancer Market Outlook
13. Country-Wise Microsatellite Stable Colorectal Cancer Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Microsatellite Stable Colorectal Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Microsatellite Stable Colorectal Cancer Market Outlook 2032
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com